PortfoliosLab logo
ADMA vs. AMSC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ADMA and AMSC is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

ADMA vs. AMSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%December2025FebruaryMarchApril
22.87%
-30.45%
ADMA
AMSC

Key characteristics

Sharpe Ratio

ADMA:

3.72

AMSC:

0.68

Sortino Ratio

ADMA:

4.26

AMSC:

1.62

Omega Ratio

ADMA:

1.56

AMSC:

1.18

Calmar Ratio

ADMA:

5.51

AMSC:

0.63

Martin Ratio

ADMA:

17.52

AMSC:

2.10

Ulcer Index

ADMA:

15.03%

AMSC:

29.45%

Daily Std Dev

ADMA:

71.00%

AMSC:

91.37%

Max Drawdown

ADMA:

-91.28%

AMSC:

-99.57%

Current Drawdown

ADMA:

-2.90%

AMSC:

-97.13%

Fundamentals

Market Cap

ADMA:

$5.85B

AMSC:

$797.88M

EPS

ADMA:

$0.91

AMSC:

$0.09

PE Ratio

ADMA:

26.93

AMSC:

224.67

PEG Ratio

ADMA:

0.00

AMSC:

-0.06

PS Ratio

ADMA:

13.31

AMSC:

4.03

PB Ratio

ADMA:

16.48

AMSC:

4.14

Total Revenue (TTM)

ADMA:

$344.58M

AMSC:

$156.16M

Gross Profit (TTM)

ADMA:

$180.30M

AMSC:

$44.16M

EBITDA (TTM)

ADMA:

$123.41M

AMSC:

$6.89M

Returns By Period

In the year-to-date period, ADMA achieves a 38.78% return, which is significantly higher than AMSC's -19.41% return. Both investments have delivered pretty close results over the past 10 years, with ADMA having a 11.13% annualized return and AMSC not far ahead at 11.60%.


ADMA

YTD

38.78%

1M

19.96%

6M

40.33%

1Y

265.03%

5Y*

51.47%

10Y*

11.13%

AMSC

YTD

-19.41%

1M

9.43%

6M

-15.46%

1Y

60.73%

5Y*

28.56%

10Y*

11.60%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ADMA vs. AMSC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA
The Risk-Adjusted Performance Rank of ADMA is 9898
Overall Rank
The Sharpe Ratio Rank of ADMA is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of ADMA is 9898
Sortino Ratio Rank
The Omega Ratio Rank of ADMA is 9797
Omega Ratio Rank
The Calmar Ratio Rank of ADMA is 9999
Calmar Ratio Rank
The Martin Ratio Rank of ADMA is 9898
Martin Ratio Rank

AMSC
The Risk-Adjusted Performance Rank of AMSC is 7676
Overall Rank
The Sharpe Ratio Rank of AMSC is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of AMSC is 7979
Sortino Ratio Rank
The Omega Ratio Rank of AMSC is 7474
Omega Ratio Rank
The Calmar Ratio Rank of AMSC is 7777
Calmar Ratio Rank
The Martin Ratio Rank of AMSC is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ADMA vs. AMSC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for ADMA, currently valued at 3.72, compared to the broader market-2.00-1.000.001.002.003.00
ADMA: 3.72
AMSC: 0.68
The chart of Sortino ratio for ADMA, currently valued at 4.26, compared to the broader market-6.00-4.00-2.000.002.004.00
ADMA: 4.26
AMSC: 1.62
The chart of Omega ratio for ADMA, currently valued at 1.56, compared to the broader market0.501.001.502.00
ADMA: 1.56
AMSC: 1.18
The chart of Calmar ratio for ADMA, currently valued at 5.50, compared to the broader market0.001.002.003.004.005.00
ADMA: 5.51
AMSC: 1.05
The chart of Martin ratio for ADMA, currently valued at 17.52, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
ADMA: 17.52
AMSC: 2.10

The current ADMA Sharpe Ratio is 3.72, which is higher than the AMSC Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of ADMA and AMSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.008.00December2025FebruaryMarchApril
3.72
0.68
ADMA
AMSC

Dividends

ADMA vs. AMSC - Dividend Comparison

Neither ADMA nor AMSC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADMA vs. AMSC - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, smaller than the maximum AMSC drawdown of -99.57%. Use the drawdown chart below to compare losses from any high point for ADMA and AMSC. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchApril
-2.90%
-46.07%
ADMA
AMSC

Volatility

ADMA vs. AMSC - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 24.81%, while American Superconductor Corporation (AMSC) has a volatility of 26.86%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than AMSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%December2025FebruaryMarchApril
24.81%
26.86%
ADMA
AMSC

Financials

ADMA vs. AMSC - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and American Superconductor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
117.55M
61.40M
(ADMA) Total Revenue
(AMSC) Total Revenue
Values in USD except per share items

ADMA vs. AMSC - Profitability Comparison

The chart below illustrates the profitability comparison between ADMA Biologics, Inc. and American Superconductor Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-80.0%-60.0%-40.0%-20.0%0.0%20.0%40.0%60.0%AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
53.9%
26.6%
(ADMA) Gross Margin
(AMSC) Gross Margin
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported a gross profit of 63.33M and revenue of 117.55M. Therefore, the gross margin over that period was 53.9%.
AMSC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, American Superconductor Corporation reported a gross profit of 16.33M and revenue of 61.40M. Therefore, the gross margin over that period was 26.6%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported an operating income of 38.32M and revenue of 117.55M, resulting in an operating margin of 32.6%.
AMSC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, American Superconductor Corporation reported an operating income of 1.32M and revenue of 61.40M, resulting in an operating margin of 2.1%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported a net income of 111.90M and revenue of 117.55M, resulting in a net margin of 95.2%.
AMSC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, American Superconductor Corporation reported a net income of 2.47M and revenue of 61.40M, resulting in a net margin of 4.0%.